Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTVG215)

• DTT Name: Debrisoquine 4-hydroxylase (CYP2D6) DTT Info
• Gene Name: CYP2D6

Molecule-Related Drug & Molecule List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Glutethimide	DMGE0CW	Insomnia	7A00-7A0Z	Approved	[1]

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ISOQUINE	DMR17YI	Malaria	1F40-1F45	Phase 1	[2]

45 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(2-hydroxy-3-phenoxypropyl)(propan-2-yl)amine	DMCHJL1	Discovery agent	N.A.	Investigative	[3]
(5-(pyridin-3-yl)furan-2-yl)methanamine	DMTC5VF	Discovery agent	N.A.	Investigative	[4]
(5-phenylfuran-2-yl)methanamine	DMORD8S	Discovery agent	N.A.	Investigative	[4]
(5-pyridin-3-yl-furan-2-yl)methanethiol	DMKC2BE	Discovery agent	N.A.	Investigative	[4]
1,5-bis(4-hydroxyphenyl)penta-1,4-dien-3-one	DMPOAB7	Discovery agent	N.A.	Investigative	[5]
1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)	DMYZ548	Discovery agent	N.A.	Investigative	[6]
1-(4-Butoxy-phenyl)-1H-imidazole	DMOEGZV	Discovery agent	N.A.	Investigative	[7]
1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)	DMI479T	Discovery agent	N.A.	Investigative	[6]
1H-1,2,3-benzotriazol-1-amine	DM9KAI5	Discovery agent	N.A.	Investigative	[8]
2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole	DMZVBPG	Discovery agent	N.A.	Investigative	[9]
2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine	DMUIVS9	Discovery agent	N.A.	Investigative	[7]
2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol	DMUGAT8	Discovery agent	N.A.	Investigative	[10]
2-Hexyloxy-5-imidazol-1-yl-pyridine	DMKORTS	Discovery agent	N.A.	Investigative	[7]
2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DM8A3NI	Discovery agent	N.A.	Investigative	[7]
3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine	DMN75RD	Discovery agent	N.A.	Investigative	[11]
3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DMTLJMF	Discovery agent	N.A.	Investigative	[7]
4-(3-Pent-1-ynyl-benzyl)-1H-imidazole	DMEYV1B	Discovery agent	N.A.	Investigative	[12]
4-(3-Phenylethynyl-benzyl)-1H-imidazole	DMS4JVT	Discovery agent	N.A.	Investigative	[12]
4-(Spiro[chromene-2,4'-piperidine]-4-yl)benzamide	DM0XDG6	Discovery agent	N.A.	Investigative	[13]
4-methylaminomethyl-7-methoxycoumarin	DMI1L6Q	Discovery agent	N.A.	Investigative	[14]
4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine	DM9UGO0	Discovery agent	N.A.	Investigative	[7]
4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DM7LV5A	Discovery agent	N.A.	Investigative	[7]
4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol	DMK4ICB	Discovery agent	N.A.	Investigative	[10]
4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol	DM7ERYJ	Discovery agent	N.A.	Investigative	[10]
6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)	DMZHFWX	Discovery agent	N.A.	Investigative	[6]
Bis-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine	DMQ98H5	Discovery agent	N.A.	Investigative	[15]
BMS-694153	DM8PA3U	Migraine	8A80	Investigative	[16]
BS 7581	DM1VF6H	Discovery agent	N.A.	Investigative	[17]
BS 7840	DMDYNBT	Discovery agent	N.A.	Investigative	[17]
BS 9106	DMQ2FDA	Discovery agent	N.A.	Investigative	[17]
Desethyl isoquine	DM47JFS	Discovery agent	N.A.	Investigative	[2]
DIHYDROCUBEBIN	DMZL7R6	Discovery agent	N.A.	Investigative	[18]
GB-12819	DM7B5HA	Discovery agent	N.A.	Investigative	[17]
GBR 12530	DMPOML4	Discovery agent	N.A.	Investigative	[17]
GBR-12289	DM2CUNP	Discovery agent	N.A.	Investigative	[17]
GNF-PF-2094	DM9J35R	Discovery agent	N.A.	Investigative	[19]
GNF-PF-4292	DMXWYMH	Discovery agent	N.A.	Investigative	[20]
GNF-PF-5411	DMZNAEQ	Discovery agent	N.A.	Investigative	[20]
Go-Y022	DMZNUAD	Discovery agent	N.A.	Investigative	[5]
ICI-199441	DMEWZ80	Discovery agent	N.A.	Investigative	[21]
Kaempferol-3-O-methyl ether	DMBG7X1	Discovery agent	N.A.	Investigative	[22]
Methyl-(5-pyridin-3-yl-thiophen-2-yl)-amine	DMQU9VD	Discovery agent	N.A.	Investigative	[15]
ML-3163	DM3S5UC	Discovery agent	N.A.	Investigative	[23]
Prodipine	DMGIF1L	Discovery agent	N.A.	Investigative	[20]
SB-210313	DM5EWQN	Discovery agent	N.A.	Investigative	[24]

References

• [1] A study of the effects of large doses of glutethimide that were used for self-poisoning during pregnancy on human fetuses. Toxicol Ind Health. 2008 Feb-Mar;24(1-2):69-78.
• [2] Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for ... J Med Chem. 2009 Mar 12;52(5):1408-15.
• [3] A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3816-20.
• [4] Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem. 2006 Nov 30;49(24):6987-7001.
• [5] Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues. Eur J Med Chem. 2008 Aug;43(8):1621-31.
• [6] 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. J Med Chem. 2010 Jul 8;53(13):4989-5001.
• [7] Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):333-6.
• [8] Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. Bioorg Med Chem Lett. 2001 Dec 3;11(23):2993-5.
• [9] Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active hi... J Med Chem. 2010 May 13;53(9):3840-4.
• [10] New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxyst... J Med Chem. 2009 Nov 12;52(21):6724-43.
• [11] Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on pote... J Med Chem. 2008 Aug 28;51(16):5064-74.
• [12] 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists. J Med Chem. 2008 May 22;51(10):2944-53.
• [13] Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) b... J Med Chem. 2009 Sep 24;52(18):5685-702.
• [14] Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists. J Med Chem. 2010 Oct 14;53(19):7129-39.
• [15] 5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6. J Med Chem. 2005 Jan 13;48(1):224-39.
• [16] Discovery of (R)-4-(8-fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan... J Med Chem. 2008 Aug 28;51(16):4858-61.
• [17] Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking. J Med Chem. 2006 Apr 20;49(8):2417-30.
• [18] Potent CYP3A4 inhibitory constituents of Piper cubeba. J Nat Prod. 2005 Jan;68(1):64-8.
• [19] Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines. Bioorg Med Chem Lett. 2010 Jan 1;20(1):228-31.
• [20] Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. J Med Chem. 1993 Apr 30;36(9):1136-45.
• [21] Arylacetamide kappa opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activity. Bioorg Med Chem Lett. 2005 May 16;15(10):2647-52.
• [22] Sesquiterpenes and flavonol glycosides from Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activities. J Nat Prod. 2004 Jul;67(7):1079-83.
• [23] Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes. J Med Chem. 2003 Jul 17;46(15):3230-44.
• [24] Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes. Bioorg Med Chem Lett. 1998 Nov 17;8(22):3111-6.